VHT Fact Sheet: Vanguard Health Care ETF
Share
$326.69
close, Nov 20, 2026
Over the year to Nov 19, 2026, VHT returned +17.5% in total and charged 0.09% a year.
- 1-year total return
- +17.8%
- FHLC +17.9% to Nov 20, 2026
- Expense ratio
- 0.09%
- a year
- Net assets
- $20.8bn
- on Oct 31, 2026
Growth of $10,000, 1 year
VHT $11,753 +17.5% · FHLC $11,765 +17.6% · Total return, distributions reinvested, Nov 19, 2025 to Nov 19, 2026.
Returns
WindowTotal return
1 month−1.7%
3 months0.0%
Year to date+14.7%
1 year+17.8%
3 years+45.0%
5 years+37.4%
Total return, distributions reinvested, each window to Nov 20, 2026.
Ten largest positions
HoldingWeight
Eli Lilly & Co14.69%
Johnson & Johnson8.40%
AbbVie Inc6.74%
UnitedHealth Group Inc4.78%
Merck & Co Inc4.78%
Thermo Fisher Scientific Inc3.35%
Amgen Inc3.25%
Gilead Sciences Inc2.74%
Abbott Laboratories2.39%
Pfizer Inc2.25%
VHT top ten by weight, 53.4% of the fund, of its 410 equity positions, from the holdings filed for Oct 31, 2026.
Facts
Equity fund · Tracks the MSCI US Investable Market Index (IMI)/Health Care 25/50 · First traded Jan 30, 2004 · Benchmark MSCI US Investable Market Index (IMI)/Health Care 25/50, measured by FHLC, which tracks the same index